Baysa Anton, Maghazachi Azzam A, Sand Kristin Larsen, Campesan Marika, Zaglia Tania, Mongillo Marco, Giorgio Marco, Di Lisa Fabio, Gullestad Lars, Mariero Lars H, Vaage Jarle, Valen Guro, Stensløkken Kåre-Olav
Department of Molecular Medicine, Institute of Basic Medical Science University of Oslo, Norway.
Department of Biomedical Sciences, University of Padua, Padua, Italy.
Biochem Biophys Res Commun. 2023 Feb 12;644:70-78. doi: 10.1016/j.bbrc.2022.12.085. Epub 2022 Dec 30.
During myocardial infarction, cellular debris is released, causing a sterile inflammation via pattern recognition receptors. These reactions amplify damage and promotes secondary heart failure. The pattern recognition receptor, Toll-like receptor 9 (TLR9) detects immunogenic fragments of endogenous DNA, inducing inflammation by NFκB. The p66ShcA adaptor protein plays an important role in both ischemic myocardial damage and immune responses. We hypothesized that p66ShcA adaptor protein promotes DNA-sensing signaling via the TLR9 pathway after myocardial infarction. TLR9 protein expression increased in cardiac tissue from patients with end-stage heart failure due to ischemic heart disease. Myocardial ischemia in mice in vivo induced gene expression of key TLR9 pathway proteins (MyD88 and Unc93b1). In this model, a functional link between TLR9 and p66ShcA was revealed as; (i) ischemia-induced upregulation of TLR9 protein was abrogated in myocardium of p66ShcA knockout mice; (ii) when p66ShcA was overexpressed in NFkB reporter cells stably expressing TLR9, NFkB-activation increased during stimulation with the TLR9 agonist CpG B; (iii) in cardiac fibroblasts, p66ShcA overexpression caused TLR9 upregulation. Co-immunoprecipitation showed that ShcA proteins and TLR9 may be found in the same protein complex, which was dissipated upon TLR9 stimulation in vivo. A proximity assay confirmed the co-localization of TLR9 and ShcA proteins. The systemic immune response after myocardial ischemia was dampened in p66ShcA knockout mice as interleukin-4, -17 and -22 expression in mononuclear cells isolated from spleens was reduced. In conclusion, p66ShcA adaptor may be an interaction partner and a regulator of the TLR9 pathway post-infarction.
在心肌梗死期间,细胞碎片被释放,通过模式识别受体引发无菌性炎症。这些反应会放大损伤并促进继发性心力衰竭。模式识别受体Toll样受体9(TLR9)可检测内源性DNA的免疫原性片段,通过核因子κB诱导炎症反应。p66ShcA衔接蛋白在缺血性心肌损伤和免疫反应中均起重要作用。我们推测,p66ShcA衔接蛋白在心肌梗死后通过TLR9途径促进DNA传感信号传导。在因缺血性心脏病导致终末期心力衰竭患者的心脏组织中,TLR9蛋白表达增加。体内小鼠心肌缺血可诱导关键TLR9途径蛋白(MyD88和Unc93b1)的基因表达。在该模型中,TLR9与p66ShcA之间的功能联系表现为:(i)p66ShcA基因敲除小鼠心肌中缺血诱导的TLR9蛋白上调被消除;(ii)当p66ShcA在稳定表达TLR9的NFκB报告细胞中过表达时,在用TLR9激动剂CpG B刺激期间,NFκB激活增加;(iii)在心脏成纤维细胞中,p66ShcA过表达导致TLR9上调。免疫共沉淀显示,ShcA蛋白和TLR9可能存在于同一蛋白复合物中,该复合物在体内经TLR9刺激后消散。邻近分析证实了TLR9和ShcA蛋白的共定位。p66ShcA基因敲除小鼠心肌缺血后的全身免疫反应减弱,因为从脾脏分离的单核细胞中白细胞介素-4、-17和-22的表达降低。总之,p66ShcA衔接蛋白可能是梗死后期TLR9途径的相互作用伙伴和调节因子。